This paper presents some new contextual data on five Neolithic ditched sites located in Alentejo hinterland (Perdigões, Horta do Pinheiro 6, Horta Nova 4, Estácio 6 and Cortes 1). An inventory of the available radiocarbon dates for the Neolithic (with twelve new dates) is provided and several aspects on the arising and early developments of the regional ditched enclosures are debated, e.g. spatial distribution, construction procedures, social re-cutting practices, infilling and depositional processes, diversity and possible relation among megalithic structures and ditched enclosures. Recintos de fossos neolíticos no Sul de Portugal (IV milénio AC): novos dados e novas perspectivas - O texto apresenta os dados contextuais recentemente obtidos para cinco sítios neolíticos com fossos localizados no interior alentejano (Perdigões, Horta do Pinheiro 6, Horta Nova 4, Estácio 6 e Cortes 1), reúne um inventário das datações de radiocarbono disponíveis para recintos de fossos neolíticos (publicando doze novas datas) e aborda vários aspectos relativos à emergência e desenvolvimento inicial dos recintos de fossos na região: distribuição espacial, processos construtivos, práticas sociais de recorte, processos de enchimento e deposições, diversidade e uma possível relação entre recintos megalíticos e recintos de fossos são várias das questões discutidas.

Rhinoscleroma is a chronic granulomatous infectious disease that is rare in Western Europe. We report the case of a 5-year-old Portuguese boy diagnosed with rhinoscleroma in the context of recurrent epistaxis. He had a 6-month course of antibiotic (amoxicillin plus clavulanate) therapy with full recovery.

had no significant changes in each group and between the two groups (trial:-0.29±0.9 vs. control:-0.95±1.1, p value >0.05). Height Velocity with age had a negative linear correlation and height Z score was positively related to the initial height and weight (p value < 0.05) in both groups. Conclusion In CPP, adjuvant therapy with Vitamin A and iron in combination with GnRH agonist could be considered to improve height velocity.

No abstract